The Multiple Myeloma Research Foundation (MMRF) helps accelerate the development of next generation multiple myeloma treatments to extend patient’s lives, and lead to a cure. MMRF brings treatment to multiple myeloma patients 60% faster than the average through collaboration with best in class partners in the US and Internationally. In the process, we are changing the way cancer research is conducted. MMRF, a 501(c)(3), is the number one private funder of multiple myeloma research in the United States.
Want to gain insight into promising advances in myeloma treatment from the experts? Join us, July 13, 2015
Join Us in Chicago! 5K Walk/Run September 13th.
Read the second post in our blog series on immunotherapy: Boosting the Immune Response. Read More
Always wanted to run the TCS New York City Marathon? Get in, give back! Register Today
Connect with patients, engage with experts, get the information you need! MMRF CoMMunity Gateway
Read Kathy Giusti's Newsweek Op-Ed on Tom Brokaw’s new book, A Lucky Life Interrupted. Read More
At the MMRF, we’re urgently working to develop treatments to extend your life. We can notify you about clinical trials, connect you to other patients with the same disease characteristics, bring you the latest breaking developments, and more. We’re learning every day. You can too.LEARN MORE
The model we have created for drug discovery and development is revolutionary. It brings multiple myeloma treatments to trial 60% faster than average. It has resulted in seven multiple myeloma drugs receiving FDA approval in the time it normally takes for one. Through the power of new technology, genomics and immunology, it has extended lives that would have been lost to multiple myeloma yesterday. And it is accelerating all the time. Learn how we are doing it.